View Author
patient tumor receptor treatment study cabergoline somatostatin cortisol thymu expression group effect octreotide hormone endocrinol binding growth subtype disease month secretion dopamine thymic level adenoma cushing microadenoma metab cortisol secretion result cortisol levels endocrinology tissue score journal 2 receptor som 230 cabergoline treatment serum factor response adenomas table agonist corticotroph lambert value syndrome sst 2a questionnaire bromocriptine thymocyte section number cushingqol suppression neuropeptide hrqol therapy sample range pathway van hagen pm health prolactin dopamine agonists function somatostatin receptors system lamberts swj control ferone quinagolide mtor pathway cancer glucose inhibitor van koetsveld pm mtor inhibitors organ
9 Most Recent Publications
|
Role of the mTOR pathway in normal and tumoral adrenal cells
(Article)
Martino, M.C. de Koetsveld, P.M. van Pivonello, R. Hofland, L.J. |
2010-09-01
|
|
The medical treatment of Cushing's disease: Effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery
(Article)
Pivonello, R. Martino, M.C. de Cappabianca, P. Leo, M. de Faggiano, A. Lombardi, G. Hofland, L.J. Lamberts, S.W.J. Colao, A. |
2009-01-01
|
|
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire
(Article)
Webb, S.M. Badia, X. Glusman, J.E. Baarahona, M.J. Colao, A. Strasburger, C.J. Tabarin, A. Aken, M.O. van Pivonello, R. Stalla, G.K. Lamberts, S.W.J. |
2008-05-01
|
|
Correlation of in vitro and in vivo somatotropic adenoma responsiveness to somatostatin analogs and dopamine agonists with immunohistochemical evaluation of somatostatin and dopamine receptors and electron microscopy
(Article)
Ferone, D. Herder, W.W. de Pivonello, R. Kros, J.M. Koetsveld, P.M. van Jong, A.A.W. de Minuto, F. Colao, A. Lamberts, S.W.J. Hofland, L.J. |
2008-04-01
|
|
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas
(Article)
Fedele, M. Martino, I. de Hofland, L.J. Lombardi, G. Colao, A. Fusco, A. Pivonello, R. Ciarmiello, A. Caro, M.L.D.B. de Visone, R. Palmieri, D. Pierantoni, G.M. Arra, C. Schmid, H.A. |
2007-05-01
|
|
Dopamine receptor expression and function in corticotroph ectopic tumors.
(Article)
Pivonello, R. Ferone, D. Herder, W.W. de Faggiano, A. Bodei, L. Krijger, R.R. de Lombardi, G. Colao, A. Lamberts, S.W.J. Hofland, L.J. |
2007-01-01
|
|
Dopamine receptor expression and function in corticotroph pituitary tumors
(Article)
Pivonello, R. Lamberts, S.W.J. Hofland, L.J. Ferone, D. Herder, W.W. de Kros, J.M. Caro, M.L. de Arvigo, M. Annunziato, L. Lombardi, G. Colao, A. |
2004-01-01
|
|
Age-related decrease of somatostatin receptor number in the normal human thymus
(Article)
Ferone, D. Pivonello, R. Hagen, P.M. van Waaijers, M. Zuijderwijk, J. Colao, A. Lombardi, G. Bogers, A.J.J.C. Lamberts, S.W.J. Hofland, L.J. |
2000-01-01
|
|
Physiological and pathophysiological role of somatostatin receptors in the human thymus
(Article)
Ferone, D. Hagen, P.M. van Pivonello, R. Colao, A. Lamberts, S.W.J. Hofland, L.J. |
2000-01-01
|
